Literature DB >> 5323379

Clinical experience with nucleosides in herpes simplex eye infections in man and animals.

I H Leopold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5323379     DOI: 10.1111/j.1749-6632.1965.tb12551.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  9 in total

Review 1.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2015-01-09

2.  Advances in antiviral chemotherapy.

Authors:  R A Buchanan
Journal:  Can Med Assoc J       Date:  1979-01-06       Impact factor: 8.262

3.  Phosphorylation of 5-bromodeoxycytidine in cells infected with herpes simplex virus.

Authors:  G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

4.  Herpes simplex encephalitis treated with intravenous idoxuridine.

Authors:  A D Evans; O P Gray; M H Miller; E R Jones; R D Weeks; C E Wells
Journal:  Br Med J       Date:  1967-05-13

Review 5.  The effects of therapeutic measures in diseases caused by viruses.

Authors:  R P Larke
Journal:  Can Med Assoc J       Date:  1966-11-05       Impact factor: 8.262

6.  The treatment of herpes simplex virus epithelial keratitis.

Authors:  K R Wilhelmus
Journal:  Trans Am Ophthalmol Soc       Date:  2000

Review 7.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

8.  Antiviral activity of cytarabine in herpesvirus-infected rats.

Authors:  H E Renis
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

9.  Isotope encephalography in the management of acute herpesvirus encephalitis.

Authors:  A S Bligh; C M Weaver; C E Wells
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-10       Impact factor: 10.154

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.